Do immune system and microbiome-gut-brain axis interactions associate with major depressive disorder?

Area of Science:

• Neuroscience
• Immunology
• Microbiology

Background:

• Major depressive disorder (MDD) is a prevalent psychiatric condition with unclear pathogenesis.
• Growing evidence links the immune system, gut microbiota, and central nervous system interactions to MDD.

Purpose of the Study:

• To elucidate the immune-mediated mechanisms underlying MDD.
• To explore the role of gut microbiota dysbiosis in neuroinflammation and its impact on brain function.

Main Methods:

• Review of current research on the gut-brain axis in MDD.
• Analysis of immune signaling pathways, gut barrier integrity, and neuroinflammation.

Main Results:

• Gut microbiota dysbiosis contributes to neuroinflammation and blood-brain barrier dysfunction via immune-to-brain and gut-to-brain communication.
• Mechanisms include impaired intestinal barrier, systemic inflammation, glial cell activation, and neuronal injury.
• Conversely, beneficial gut microbiota promote neuroprotection and maintain brain integrity.

Conclusions:

• The gut-brain axis, involving immune and microbial factors, is crucial in MDD pathophysiology.
• These findings highlight potential biomarkers and novel therapeutic strategies for MDD targeting the gut-brain axis.